Advanced Biomedical Research

REVIEW ARTICLE
Year
: 2022  |  Volume : 11  |  Issue : 1  |  Page : 63-

The prominent role of miR-942 in carcinogenesis of tumors


Negar Yadegar1, Zahra Dadashi2, Kimiya Shams3, Mahdis Mohammadi4, Mahya Abyar5, Milad Rafat6 
1 Department of Medical Laboratory Science, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
2 Department of Biological Science, Kharazmi University, Tehran, Iran
3 Department of Biotechnology, Faculty of Biological Science, Islamic Azad University, North Tehran Branch, Tehran, Iran
4 Department of Biotechnology, Faculty of Biological Science, Islamic Azad University East Tehran Branch, Iran
5 Department of Molecular Genetics, Islamic Azad University, East Tehran Branch, Tehran, Iran
6 Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran

Correspondence Address:
Dr. Milad Rafat
Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas
Iran

As a family of short noncoding RNAs, MicroRNAs have been identified as possible biomarkers for cancer discovery and assist in therapy control due to their epigenetic involvement in gene expression and other cellular biological processes. In the present review, the evidence for reaching the clinical effect and the molecular mechanism of miR-942 in various kinds of cancer is amassed. Dysregulation of miR-942 amounts in different kinds of malignancies, as bladder cancer, esophageal squamous cell carcinoma, breast cancer, cervical cancer, gastric cancer, colorectal cancer, Kaposi's sarcoma, melanoma, Hepatocellular carcinoma, nonsmall-cell lung cancer, oral squamous cell carcinoma, osteosarcoma, ovarian cancer, pancreatic ductal adenocarcinoma, renal cell carcinoma, and prostate cancer has stated a considerable increase or decrease in its level indicating its function as oncogene or tumor suppressor. MiR-942 is included in cell proliferation, migration, and invasion through cell cycle pathways, including pathways of transforming growth factor-beta signaling pathways, Wnt pathway, JAK/STAT pathway, PI3K/AKT pathway, apoptosis pathway, hippo signaling pathway, lectin pathway, interferon-gamma signaling, signaling by G-protein coupled receptor, developmental genes, nuclear factor-kappa B pathway, Mesodermal commitment pathway, and T-cell receptor signaling in cancer. An important biomarker, MiR-942 is a potential candidate for prediction in several cancers. The present investigation introduced miR-942 as a prognostic marker for early discovery of tumor progression, metastasis, and development.


How to cite this article:
Yadegar N, Dadashi Z, Shams K, Mohammadi M, Abyar M, Rafat M. The prominent role of miR-942 in carcinogenesis of tumors.Adv Biomed Res 2022;11:63-63


How to cite this URL:
Yadegar N, Dadashi Z, Shams K, Mohammadi M, Abyar M, Rafat M. The prominent role of miR-942 in carcinogenesis of tumors. Adv Biomed Res [serial online] 2022 [cited 2022 Aug 14 ];11:63-63
Available from: https://www.advbiores.net/article.asp?issn=2277-9175;year=2022;volume=11;issue=1;spage=63;epage=63;aulast=Yadegar;type=0